ArticleComputational and structural biotechnology journal2025
SUMO-LMNet: Lossless mapping network for predicting SUMOylation sites in SUMO1 and SUMO2 using high-dimensional features.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in plant salt stress research: from predictive models to multi-omics integration.Journal of experimental botany · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate SUMOylation site prediction is crucial for deciphering gene regulation and disease mechanisms. However, distinguishing SUMO1 and SUMO2 modifications remains a major challenge due to their structural similarities. Conventional prediction models often struggle to differentiate between these paralogues, limiting their applicability in biological research. To address this, we introduce SUMO-LMNet, a deep learning-based framework for the precise prediction of SUMO1 and SUMO2 sites. Unlike previous models, SUMO-LMNet integrates a lossless mapping strategy and deep learning architectures to enhance both prediction accuracy and interpretability. Our model extracts high-dimensional features from sequences and transforms them into two-dimensional feature maps, enabling convolutional neural networks (CNNs) to effectively capture both local and global dependencies within the data. By leveraging a Lossless Mapping Network (LM-Net), this approach preserves the original feature space, ensuring that feature integrity is retained without loss of spatial information. While Grad-CAM highlights key features in individual predictions, it lacks consistency across samples and does not provide a dataset-wide evaluation of feature importance. To address this, we introduce Combined Heatmap Feature Analysis (CHFA), which systematically aggregates feature importance across multiple samples, providing a more reliable and interpretable dataset-wide assessment. Experimental results reveal distinct feature dependencies between SUMO1 and SUMO2, underscoring the necessity of paralogue-specific predictive models. Through a systematic comparison of multiple neural network architectures, we demonstrate that our model achieves over 80 % accuracy in distinguishing SUMO1 and SUMO2 modification sites. By prioritizing candidate sites for further study, our model aids experimental design and accelerates the discovery of biologically relevant SUMOylation targets. SUMO-LMNet is publicly available at https://predictor.isu.edu.tw/sumo-lmnet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.